Related references
Note: Only part of the references are listed.Statins and primary liver cancer: a meta-analysis of observational studies
Danitza Pradelli et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2013)
Statin use and risk of breast cancer: a meta-analysis of observational studies
Krishna Undela et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Statin use and the risk of renal cell carcinoma in 2 prospective US cohorts
Wei Liu et al.
CANCER (2012)
Statin use and risk of pancreatic cancer: a meta-analysis
Xiaobing Cui et al.
CANCER CAUSES & CONTROL (2012)
Statin use and the risk of kidney cancer: a population-based case-control study
Hui-Fen Chiu et al.
EXPERT OPINION ON DRUG SAFETY (2012)
Everyone under statin?
Helene Vaillant-Roussel et al.
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2012)
Lack of Effect of Lowering LDL Cholesterol on Cancer: Meta-Analysis of Individual Data from 175,000 People in 27 Randomised Trials of Statin Therapy
Jonathan R. Emberson et al.
PLOS ONE (2012)
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
B. Mihaylova et al.
LANCET (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Long-term Use of Cholesterol-Lowering Drugs and Cancer Incidence in a Large United States Cohort
Eric J. Jacobs et al.
CANCER RESEARCH (2011)
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
David Moher et al.
INTERNATIONAL JOURNAL OF SURGERY (2010)
Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database
Julia Hippisley-Cox et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Statins inhibit NK-cell cytotoxicity by interfering with LFA-1-mediated conjugate formation
Patrick C. Raemer et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
The double-edged sword of statin immunomodulation
Mark R. Goldstein et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2009)
The effect of HMG-CoA reductase inhibitors on naturally occurring CD4(+)CD25(+) T cells
Karin Mausner-Fainberg et al.
ATHEROSCLEROSIS (2008)
Statin-dependent suppression of the Akt/mammalian target of rapamycin signaling cascade and programmed cell death 4 up-regulation in renal cell carcinoma
Jennifer Woodard et al.
CLINICAL CANCER RESEARCH (2008)
Statins and cancer: A systematic review and meta-analysis
Jaana Kuoppala et al.
EUROPEAN JOURNAL OF CANCER (2008)
Primary Prevention of Cardiovascular Mortality and Events With Statin Treatments
Edward J. Mills et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Statins might reduce risk of renal cell carcinoma in humans: Case-control study of 500,000 veterans
Vikas Khurana et al.
UROLOGY (2008)
Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361 859 recipients
Gary D. Friedman et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2008)
Statin use and the risk of 10 cancers
Patricia F. Coogan et al.
EPIDEMIOLOGY (2007)
Statins and risk of cancer: A systematic review and metaanalysis
Danielle R. L. Browning et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Pravastatin use and the five-year incidence of cancer in coronary heart disease patients: from the prevention of coronary sclerosis study
Shinichi Sato et al.
JOURNAL OF EPIDEMIOLOGY (2006)
Statins and cancer risk - A meta-analysis
KM Dale et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
The effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: a randomised placebo-controlled trial [ISRCTN48489393]
Jane Armitage et al.
BMC MEDICINE (2005)
Statin use and cancer risk in the General Practice Research Database
JA Kaye et al.
BRITISH JOURNAL OF CANCER (2004)
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, fluvastatin, as a novel agent for prophylaxis of renal cancer metastasis
A Horiguchi et al.
CLINICAL CANCER RESEARCH (2004)
The risk of cancer in users of statins
MR Graaf et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA
HJ Park et al.
CIRCULATION RESEARCH (2002)
Microarray and biochemical analysis of lovastatin-induced apoptosis of squamous cell carcinomas
J Dimitroulakos et al.
NEOPLASIA (2002)
HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis
WWL Wong et al.
LEUKEMIA (2002)
Statins have biphasic effects on angiogenesis
M Weis et al.
CIRCULATION (2002)
3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors reduce human pancreatic cancer cell invasion and metastasis
T Kusama et al.
GASTROENTEROLOGY (2002)
Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS): Efficacy and tolerability of long-term treatment with Lovastatin in women
M Clearfield et al.
JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE (2001)
Share Paper
